Media
News
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray

Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update

"As we continue to expect EU regulatory approval in the first quarter of calendar year of 2022, we are very excited to continue to drive our commercial efforts globally.

Quotient Limited has Become Accredited as a Living Wage Employer

Quotient Limited was accredited as a Living Wage Employer. The Living Wage commitment will see that everyone working at Quotient Limited receive a minimum hourly wage of £9.50 in the UK or £10.85 in London.

360Dx: Quotient Launching Multimodal, Multiplex Microarray for Transfusion Diagnostics

NEW YORK ─ Microarray test developer Quotient has entered the market for transfusion diagnostic testing with a multiplex, multimodal platform and is eyeing the development of the system for additional diagnostic applications.

Quotient Limited Celebrates World Blood Donor Day 2021

 

 

MosaiQ by Quotient Wins Prestigious Red Dot Design Award

JERSEY, Channel Islands,12 April 2021 (GLOBE NEWSWIRE) --Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ™ by Quotient system. 

Quotient Virtual Tour - Edinburgh, UK

Quotient Limited Wins 2021 BIG Innovation Award

JERSEY, Channel Islands, 12 January 2021(GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group.

Quotient Virtual Tour - Eysins, Switzerland

MosaiQ at Bloodworks Northwest Seattle, WA

Take an insider look at how our MosaiQ instrument is used at Bloodworks Northwest, and hear what a Bloodworks technologist and a donor have to say about our technology: